Dashboard
Manage Tickers

ELDNEledon Pharmaceuticals, Inc.

Nasdaq https://eledon.com/


$ 2.48 $ 0.11 (4.78 %)    

Friday, 03-May-2024 12:14:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 2.41
$ 2.48
$ 2.40 x 100
$ 0.00 x 0
$ 2.48 - $ 2.48
$ 1.07 - $ 2.95
178,489
na
59.33M
$ 0.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-24-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-17-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-28-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-07-2018 06-30-2018 10-Q
24 05-11-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-08-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-03-2017 03-31-2017 10-Q
29 03-03-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 03-10-2016 12-31-2015 10-K
34 11-10-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 05-12-2015 03-31-2015 10-Q
37 03-26-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Watching Eledon Pharmaceuticals, Acumen Ph...
04/18/2024 15:41:59

https://blog.tipranks.com/these-2-strong-buy-penny-stocks-are-poised-for-over-300-gains-say-analysts/  

eledon-pharma-q4-2023-gaap-eps-032-beats-039-estimate
Eledon Pharma Q4 2023 GAAP EPS $(0.32) Bea...
03/28/2024 20:07:10

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39)...

eledon-pharmaceuticals-reports-12th-participant-enrolled-in-phase-2-bestow-trial-evaluating-tegoprubart-for-prevention-of-organ-rejection
Eledon Pharmaceuticals Reports 12th Partic...
03/25/2024 20:58:05

hc-wainwright--co-reiterates-buy-on-eledon-pharma-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
03/22/2024 10:35:26

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $13 price ...

kidney-transplant-from-genetically-edited-pig-boston-patient-with-end-stage-renal-disease-becomes-first-to-receive
Kidney Transplant From Genetically Edited ...
03/21/2024 18:35:57

Eledon Pharmaceuticals announces successful use of tegoprubart in kidney xenotransplant. Promising results show its potential t...

eledon-pharmaceuticals-announces-use-of-tegoprubart-in-first-ever-transplant-of-genetically-modified-kidney-from-a-pig-to-a-human
Eledon Pharmaceuticals Announces Use Of Te...
03/21/2024 14:31:59

Historic kidney xenotransplantation procedure conducted at Massachusetts General HospitalTegoprubart administration has now bee...

eledon-pharmaceuticals-provides-guidance-for-anticipated-upcoming-2024-milestones
Eledon Pharmaceuticals Provides Guidance F...
01/04/2024 21:44:05

Anticipated 2024 Milestones:  First half of 2024: Report updated interim clinical data from the ongoing Phase 1b trial of te...

expert-ratings-for-eledon-pharma
Expert Ratings for Eledon Pharma
11/13/2023 15:00:19

hc-wainwright--co-reiterates-buy-on-eledon-pharma-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
11/13/2023 12:47:24

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $13 price ...

eledon-pharma-q3-eps-035-beats-050-estimate
Eledon Pharma Q3 EPS $(0.35) Beats $(0.50)...
11/09/2023 21:52:00

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.50)...

eledon-reports-updated-data-from-ongoing-phase-1b-trial-evaluating-tegoprubart-for-prevention-of-rejection-in-kidney-transplantation
Eledon Reports Updated Data From Ongoing P...
11/02/2023 13:22:42

Data from 11 participants demonstrates tegoprubart successfully prevented kidney transplant rejection and was generally safe an...

hc-wainwright--co-maintains-buy-on-eledon-pharma-lowers-price-target-to-13
HC Wainwright & Co. Maintains Buy on Eledo...
10/24/2023 11:04:32

HC Wainwright & Co. analyst Vernon Bernardino maintains Eledon Pharma (NASDAQ:ELDN) with a Buy and lowers the price targ...

eledon-pharmaceuticals-will-present-at-the-american-society-of-nephrologys-kidney-week-2023-annual-meeting-highlighting-new-data-from-eledons-ongoing-open-label-phase-1b-trial-of-tegoprubart-for-the-prevention-of-rejection-in-kidney-transplantation
Eledon Pharmaceuticals Will Present At The...
10/13/2023 11:07:11

benzingas-top-ratings-upgrades-downgrades-for-september-27-2023
Benzinga's Top Ratings Upgrades, Downgrade...
09/27/2023 15:00:45

noble-capital-markets-initiates-coverage-on-eledon-pharma-with-outperform-rating-announces-price-target-of-10
Noble Capital Markets Initiates Coverage O...
09/27/2023 13:57:28

Noble Capital Markets analyst Robert LeBoyer initiates coverage on Eledon Pharma (NASDAQ:ELDN) with a Outperform rating and ...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
09/27/2023 13:06:07

eledon-pharmaceuticals-says-that-tegoprubart-was-used-as-a-component-of-the-chronic-immunosuppressive-regimen-administered-after-second-ever-transplant-of-a-genetically-modified-heart-from-a-pig-to-a-human
Eledon Pharmaceuticals Says That Tegopruba...
09/25/2023 11:04:14

 The procedure was completed on September 20th at University of Maryland Medical Center on a 58-year-old male suffering from he...

eledon-pharmaceuticals-announces-publication-of-data-showing-treatment-with-tegoprubart-promotes-kidney-islet-allograft-survival-and-function-in-nonhuman-primates
Eledon Pharmaceuticals Announces Publicati...
09/06/2023 11:28:12

eledon-pharmaceuticals-has-dosed-the-first-participant-in-the-phase-2-bestow-trial-evaluating-tegoprubart-for-the-prevention-of-organ-rejection-in-patients-receiving-a-kidney-transplant
Eledon Pharmaceuticals Has Dosed The First...
09/05/2023 11:05:30

cantor-fitzgerald-reiterates-overweight-on-eledon-pharma-maintains-9-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/22/2023 13:44:14

Cantor Fitzgerald analyst Alethia Young reiterates Eledon Pharma (NASDAQ:ELDN) with a Overweight and maintains $9 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION